Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Trial: The Effects of Intravenous Heme Arginate on HO-1 Expression and Oxidative Stress in the Human Heart

NCT02314780 is registered in ClinicalTrials.gov with Martin Andreas, M.D. as lead sponsor.

NCT NCT02314780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02314780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Trial: The Effects of Intravenous Heme Arginate on HO-1 Expression and Oxidative Stress in the Human Heart
Lead sponsor
Martin Andreas, M.D.
Phase
Phase 2
Overall status
Completed
Start date
March 29, 2015
Completion date
June 13, 2017
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial ischemia